[
  {
    "ts": "2025-11-22T22:13:07+00:00",
    "headline": "Is ResMed's 10% Year-to-Date Gain Justified After Recent Industry Headlines?",
    "summary": "Ever wondered if ResMed stock is actually a steal or quietly overhyped? You're not alone. This article will dig beneath the surface to find out. Shares have seen modest gains recently, with the price up 2.6% over the past week and nearly 10% year-to-date. However, the last month saw a slight decline of 5.9%. Several headlines have been swirling around ResMed, from industry-wide updates in digital health and respiratory care to regulatory news shaping the medical device market. These stories...",
    "url": "https://finance.yahoo.com/news/resmeds-10-date-gain-justified-221307383.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "0c126b07-502e-3653-bfe7-5fd399ec5b97",
      "content": {
        "id": "0c126b07-502e-3653-bfe7-5fd399ec5b97",
        "contentType": "STORY",
        "title": "Is ResMed's 10% Year-to-Date Gain Justified After Recent Industry Headlines?",
        "description": "",
        "summary": "Ever wondered if ResMed stock is actually a steal or quietly overhyped? You're not alone. This article will dig beneath the surface to find out. Shares have seen modest gains recently, with the price up 2.6% over the past week and nearly 10% year-to-date. However, the last month saw a slight decline of 5.9%. Several headlines have been swirling around ResMed, from industry-wide updates in digital health and respiratory care to regulatory news shaping the medical device market. These stories...",
        "pubDate": "2025-11-22T22:13:07Z",
        "displayTime": "2025-11-22T22:13:07Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qYSQ6AG4c18KIEG8bfQS1g--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/mH32bjf22B8VXoaGCZudBg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/resmeds-10-date-gain-justified-221307383.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/resmeds-10-date-gain-justified-221307383.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "RMD"
            },
            {
              "symbol": "RSMDF"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]